A stage-based framework to interpret regulatory T cell biology after heart transplantation
specificity, epigenetic stability, and blood-graft discrepancies. Future directions encompass multimarker monitoring, dynamic risk models, Treg cell therapy, and interventions like cytokine/microbiome modulation to achieve precise immunoregulation, reduce rejection, minimize complications, and improve long-term graft survival.
Authors
- M Ni
- Vuk Savković (ORCID: https://orcid.org/0000-0003-3832-4281)
- Yuansheng Wang (ORCID: https://orcid.org/0000-0002-8117-2642)
- Sini Kang
- Aijia Zheng
- Yuqing Peng
- Qing Xiong
- Xueli Wang
- Jinbiao Liu
Institutions
- Merseburg University of Applied Sciences (DE)
- Hubei Water Resources Research Institute (CN)
- Hubei University of Technology (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2026-03-31
- DOI
- https://doi.org/10.3389/fcvm.2026.1777360
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Hubei University of Technology
- Hubei University